Beta Drugs Limited (NSE:BETA)

India · Delayed Price · Currency is INR

1,341.80

+19.50 (1.47%)

At close: May 11, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Trading and Manufacturing of Pharmaceutical Products	3.62B	2.96B	2.27B	1.84B	1.16B
Trading and Manufacturing of Pharmaceutical Products Growth	22.54%	30.21%	23.54%	58.31%	27.88%
Total	3.62B	2.96B	2.27B	1.84B	1.16B
Total Growth	22.54%	30.21%	23.54%	58.31%	27.88%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	2.83B	2.50B	1.97B	1.59B	975.52M
India Growth	13.29%	26.47%	24.21%	62.92%	17.74%
Export	794.85M	460.34M	296.96M	249.04M	185.70M
Export Growth	72.66%	55.02%	19.24%	34.11%	133.48%
Total	3.62B	2.96B	2.27B	1.84B	1.16B
Total Growth	22.54%	30.21%	23.54%	58.31%	27.88%

Source: S&P Global Market Intelligence.